Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Sell
39,709
-8,102
-17% -$2.89M 0.15% 109
2025
Q4
$15.8M Sell
47,811
-24,827
-34% -$7.88M 0.17% 102
2025
Q3
$21.6M Buy
72,638
+39,111
+117% +$11.3M 0.25% 81
2025
Q2
$9.36M Sell
33,527
-16
-0% -$4.53K 0.11% 150
2025
Q1
$10.4M Sell
33,543
-1,637
-5% -$483K 0.15% 131
2024
Q4
$9.17M Sell
35,180
-123
-0.3% -$36.5K 0.12% 145
2024
Q3
$11.4M Sell
35,303
-430
-1% -$141K 0.15% 122
2024
Q2
$11.2M Sell
35,733
-2,120
-6% -$623K 0.16% 121
2024
Q1
$10.8M Sell
37,853
-1,329
-3% -$389K 0.16% 126
2023
Q4
$11.3M Buy
39,182
+1,575
+4% +$429K 0.18% 123
2023
Q3
$10.1M Sell
37,607
-640
-2% -$160K 0.18% 122
2023
Q2
$8.49M Sell
38,247
-2,020
-5% -$469K 0.15% 144
2023
Q1
$9.73M Sell
40,267
-225
-0.6% -$55.2K 0.18% 127
2022
Q4
$10.6M Buy
40,492
+598
+1% +$160K 0.21% 111
2022
Q3
$8.99M Sell
39,894
-314
-0.8% -$76.1K 0.19% 122
2022
Q2
$9.78M Sell
40,208
-270
-0.7% -$66.2K 0.2% 117
2022
Q1
$9.79M Buy
40,478
+2,527
+7% +$581K 0.17% 132
2021
Q4
$8.54M Buy
37,951
+6
+0% +$1.27K 0.14% 145
2021
Q3
$8.07M Sell
37,945
-170
-0.4% -$39.1K 0.15% 142
2021
Q2
$9.29M Buy
38,115
+3,676
+11% +$904K 0.17% 132
2021
Q1
$8.57M Buy
34,439
+9,548
+38% +$2.28M 0.17% 127
2020
Q4
$5.72M Sell
24,891
-140
-0.6% -$32.3K 0.12% 157
2020
Q3
$6.36M Sell
25,031
-532
-2% -$132K 0.15% 135
2020
Q2
$6.03M Sell
25,563
-819
-3% -$187K 0.17% 130
2020
Q1
$5.35M Sell
26,382
-9,542
-27% -$2.08M 0.17% 132
2019
Q4
$8.66M Buy
35,924
+626
+2% +$138K 0.23% 112
2019
Q3
$6.83M Buy
35,298
+1,341
+4% +$257K 0.2% 120
2019
Q2
$6.26M Buy
33,957
+450
+1% +$80.6K 0.18% 127
2019
Q1
$6.37M Sell
33,507
-310
-0.9% -$59.2K 0.19% 123
2018
Q4
$6.58M Buy
33,817
+47
+0.1% +$9.17K 0.23% 114
2018
Q3
$7M Sell
33,770
-331
-1% -$65.2K 0.22% 122
2018
Q2
$6.29M Sell
34,101
-326
-0.9% -$57.7K 0.21% 124
2018
Q1
$5.87M Buy
34,427
+193
+0.6% +$35.4K 0.2% 126
2017
Q4
$5.95M Buy
34,234
+15
+0% +$2.65K 0.21% 123
2017
Q3
$6.38M Buy
34,219
+1,334
+4% +$236K 0.23% 117
2017
Q2
$5.66M Sell
32,885
-775
-2% -$126K 0.22% 117
2017
Q1
$5.52M Buy
33,660
+700
+2% +$116K 0.22% 117
2016
Q4
$4.82M Sell
32,960
-36,966
-53% -$5.56M 0.21% 125
2016
Q3
$11.7M Buy
69,926
+9,621
+16% +$1.63M 0.51% 56
2016
Q2
$9.18M Sell
60,305
-148
-0.2% -$23K 0.4% 69
2016
Q1
$9.06M Buy
60,453
+612
+1% +$90.9K 0.4% 68
2015
Q4
$9.71M Buy
59,841
+36,835
+160% +$5.79M 0.44% 64
2015
Q3
$3.18M Buy
23,006
+1,006
+5% +$159K 0.15% 150
2015
Q2
$3.38M Buy
22,000
+7,864
+56% +$1.26M 0.15% 156
2015
Q1
$2.26M Sell
14,136
-172
-1% -$27.1K 0.1% 176
2014
Q4
$2.28M Hold
14,308
0.11% 173
2014
Q3
$2.01M Sell
14,308
-567
-4% -$74K 0.1% 176
2014
Q2
$1.76M Hold
14,875
0.09% 184
2014
Q1
$1.83M Sell
14,875
-1,258
-8% -$153K 0.09% 174
2013
Q4
$1.84M Sell
16,133
-1,405
-8% -$160K 0.09% 169
2013
Q3
$1.96M Hold
17,538
0.11% 163
2013
Q2
$1.73M Buy
+17,538
New +$1.82M 0.1% 165

Other funds holding AMGN

Whittier Trust's AMGN Position: Q1 2026 in Review

Whittier Trust reduced its Amgen (AMGN) stake by 17% in Q1 2026, selling an estimated $2.89M and leaving 39,709 shares worth $13.6M. The position accounts for 0.15% of the portfolio, ranked #109.

Whittier Trust first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.6M in Q3 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Whittier Trust held 39,709 shares of Amgen worth $13.6M as of Q1 2026.
  • Whittier Trust sold 8,102 Amgen shares in Q1 2026, an estimated $2.89M.
  • Amgen made up 0.15% of Whittier Trust's portfolio in Q1 2026, its #109 holding.
  • Whittier Trust first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Whittier Trust's Amgen position peaked at $21.6M in Q3 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.